Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 9 (September)

1. A2A adenosine receptor protects tumors from antitumor T cells.
   Proc Natl Acad Sci U S A, 103(35): 13132-7. [Abstract] [Full-text]
2. Somatic activation of KIT in distinct subtypes of melanoma.
   J Clin Oncol, 24(26): 4340-6. [Abstract] [Full-text]
3. Correlation of comparative genomic hybridization results of 100 archival uveal melanomas with patient survival.
   Cancer Genet Cytogenet, 170(1): 29-39. [Abstract] [Full-text]
4. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8.
   Pigment Cell Res, 19(5): 395-405. [Abstract] [Full-text]
5. Neoadjuvant intratumoral cytokine-loaded microspheres are superior to postoperative autologous cellular vaccines in generating systemic anti-tumor immunity.
   J Surg Oncol, 94(5): 403-12. [Abstract] [Full-text]
6. Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells.
   Biochem Biophys Res Commun, 349(2): 549-55. [Abstract] [Full-text]
7. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.
   J Clin Oncol, 24(27): 4464-71. [Abstract] [Full-text]
8. STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases.
   J Invest Dermatol, 126(10): 2272-80. [Abstract] [Full-text]
9. The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma.
   J Invest Dermatol, 126(10): 2242-6. [Abstract] [Full-text]
10. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
    Cancer, 107(6): 1331-9. [Abstract] [Full-text]
11. Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR.
    Mol Cancer, 5: 36. [Abstract] [Full-text]
12. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms.
    Int J Gynecol Pathol, 25(4): 321-9. [Abstract] [Full-text]
13. Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand.
    Hum Pathol, 37(10): 1286-94. [Abstract] [Full-text]
14. Ethnic differences among patients with cutaneous melanoma.
    Arch Intern Med, 166(17): 1907-14. [Abstract] [Full-text]
15. Inhibition of tumor invasion and metastasis by aqueous extract of the radix of Platycodon grandiflorum.
    Food Chem Toxicol, 44(11): 1890-6. [Abstract] [Full-text]
16. Sentinel-node biopsy or nodal observation in melanoma.
    N Engl J Med, 355(13): 1307-17. [Abstract] [Full-text]
17. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
    J Clin Oncol, 24(28): 4565-9. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.